{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:00:15Z","timestamp":1753891215931,"version":"3.41.2"},"reference-count":53,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T00:00:00Z","timestamp":1700697600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>With the improvement of immunosuppressive regimens, the success rate and availability of ABO-incompatible (ABO-i) kidney transplantation (KT) have gradually increased. However, the management of immunosuppression protocols and complications associated with ABO-i KT is complex. Here, we report a clinical case of ABO-i living donor KT with allograft dysfunction caused by acute blood group antibody-dependent rejection triggered by human parvovirus B19 (B19V).<\/jats:p><\/jats:sec><jats:sec><jats:title>Case report<\/jats:title><jats:p>The ABO blood group of the recipient was O, and that of the donor was B. The recipient had high baseline anti-B antibody titers (IgM, 1:1024; IgG, 1:64). Before transplantation, he completed a desensitization protocol comprising plasma exchange, double-filtration plasmapheresis, and rituximab, which maintained a low blood group antibody level and resulted in successful transplantation. Two weeks after surgery, the recipient developed a B19V infection combined with acute T-cell-mediated rejection. After the anti-rejection regimen, acute rejection (AR) was successfully reversed, but B19V persisted. One week after AR stabilization, the patient experienced acute antibody-mediated rejection that was more severe and refractory, resulting in the loss of the transplanted kidney.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Desensitization combined with immunosuppressants can lead to overimmunosuppression and cause various infections. Infections could break the accommodation state of the patient, thereby inducing AR and resulting in the loss of the transplanted kidney.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2023.1195419","type":"journal-article","created":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T14:30:42Z","timestamp":1700749842000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["ABO-incompatible living donor kidney transplantation failure due to acute blood group antibody-dependent rejection triggered by human parvovirus B19 infection: a case report and literature review"],"prefix":"10.3389","volume":"10","author":[{"given":"Lin-rui","family":"Dai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-bo","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-yu","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Song","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-jie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,11,23]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.2215\/CJN.00540118","article-title":"ABO-incompatible kidney transplant outcomes: a meta-analysis","volume":"13","author":"de Weerd","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"e208638","DOI":"10.1371\/journal.pone.0208638","article-title":"ABO-incompatible kidney transplantation as a renal replacement therapy\u2014a single low-volume center experience in Japan","volume":"13","author":"Kosoku","year":"2018","journal-title":"PLoS One"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1111\/iju.14118","article-title":"Analysis of the prevalence of systemic de novo thrombotic microangiopathy after ABO-incompatible kidney transplantation and the associated risk factors","volume":"26","author":"Tasaki","year":"2019","journal-title":"Int J Urol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"e927420","DOI":"10.12659\/AOT.927420","article-title":"Acute rejection and infectious complications in ABO- and HLA-incompatible kidney transplantations","volume":"25","author":"Ko","year":"2020","journal-title":"Ann Transpl"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1097\/TP.0000000000004109","article-title":"Infection risk in the first year after ABO-incompatible kidney transplantation: a nationwide prospective cohort study","volume":"106","author":"Hirzel","year":"2022","journal-title":"Transplantation"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"655","DOI":"10.4103\/1319-2442.261340","article-title":"ABO incompatible kidney transplantation: the Saudi experience","volume":"30","author":"Ali","year":"2019","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1159\/000510747","article-title":"Molecular mechanisms of antibody-mediated rejection and accommodation in organ transplantation","volume":"144","author":"Kenta","year":"2020","journal-title":"Nephron"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"3095","DOI":"10.2147\/JIR.S360460","article-title":"Current perspectives in ABO-incompatible kidney transplant","volume":"15","author":"Maritati","year":"2022","journal-title":"J Inflamm Res"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"e248","DOI":"10.1097\/TP.0000000000002808","article-title":"Induction of accommodation by anti\u2013complement component 5 antibody-based immunosuppression in ABO-incompatible heart transplantation","volume":"103","author":"Park","year":"2019","journal-title":"Transplantation"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1111\/ajt.15553","article-title":"Peripheral blood transcriptome analysis and development of classification model for diagnosing antibody-mediated rejection vs accommodation in ABO-incompatible kidney transplant","volume":"20","author":"Jeon","year":"2019","journal-title":"Am J Transplant"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"e12418","DOI":"10.1111\/xen.12418","article-title":"Accommodation in ABO-incompatible organ transplants","volume":"25","author":"De Mattos","year":"2018","journal-title":"Xenotransplantation"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41598-020-58436-2","article-title":"Selective plasma exchange in ABO-incompatible kidney transplantation: comparison of substitution with albumin and partial substitution with fresh frozen plasma","volume":"10","author":"Hanaoka","year":"2020","journal-title":"Sci Rep"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1007\/s10157-007-0461-z","article-title":"Recent findings in ABO-incompatible kidney transplantation: classification and therapeutic strategy for acute antibody-mediated rejection due to ABO-blood-group-related antigens during the critical period preceding the establishment of accommodation","volume":"11","author":"Takahashi","year":"2007","journal-title":"Clin Exp Nephrol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.12659\/AJCR.905633","article-title":"ABO-incompatible renal transplantation with high antibody titer: a case report","volume":"18","author":"Ray","year":"2017","journal-title":"Am J Case Rep"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/jca.21312","article-title":"Significance of isoagglutinin titer in ABO-incompatible kidney transplantation","volume":"29","author":"Won","year":"2014","journal-title":"J Clin Apher"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"e13535","DOI":"10.1111\/ctr.13535","article-title":"Human parvovirus b19 in solid organ transplantation: guidelines from the American society of transplantation infectious diseases community of practice","volume":"33","author":"Eid","year":"2019","journal-title":"Clin Transpl"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"71","DOI":"10.24875\/RIC.19002921","article-title":"Treatment strategies and outcome of parvovirus b19 infection in kidney transplant recipients: a case series and literature review of 128 patients","volume":"71","author":"Rosado-Canto","year":"2019","journal-title":"Rev Invest Clin"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1055\/s-0034-1371759","article-title":"Effects of parvovirus b19 infection in renal transplant recipients: a retrospective review of three cases","volume":"24","author":"Krishnan","year":"2015","journal-title":"Int J Angiol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1097\/MOT.0b013e3283636c20","article-title":"Kidney transplantation across HLA and ABO antibody barriers","volume":"18","author":"Becker","year":"2013","journal-title":"Curr Opin Organ Tran"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/ki.2011.497","article-title":"Pros and cons for C4d as a biomarker","volume":"81","author":"Cohen","year":"2012","journal-title":"Kidney Int"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1097\/TP.0000000000002604","article-title":"Molecular patterns discriminate accommodation and subclinical antibody-mediated rejection in kidney transplantation","volume":"103","author":"Hruba","year":"2019","journal-title":"Transplantation"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"95","DOI":"10.5527\/wjn.v8.i6.95","article-title":"Complement activation and long-term graft function in ABO-incompatible kidney transplantation","volume":"8","author":"van Sandwijk","year":"2019","journal-title":"World J Nephrol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"234","DOI":"10.3389\/fimmu.2017.00234","article-title":"ABO-incompatible kidney transplantation","volume":"8","author":"Morath","year":"2017","journal-title":"Front Immunol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.trre.2012.07.003","article-title":"ABO-incompatible kidney transplantation","volume":"27","author":"Takahashi","year":"2013","journal-title":"Transplant Rev"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1111\/trf.15672","article-title":"ABO-incompatible kidney transplantation can be successfully conducted by monitoring IgM isoagglutinin titers during desensitization","volume":"60","author":"Kim","year":"2020","journal-title":"Transfusion"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"3649","DOI":"10.1111\/ajt.16712","article-title":"Characterization of ABH-subtype donor-specific antibodies in ABO-a-incompatible kidney transplantation","volume":"21","author":"Bentall","year":"2021","journal-title":"Am J Transplant"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"807604","DOI":"10.3389\/fimmu.2021.807604","article-title":"Establishment of a hyperacute rejection model of ABO-incompatible renal transplantation in nonhuman primates","volume":"12","author":"Wang","year":"2021","journal-title":"Front Immunol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1111\/j.1600-6143.2010.03103.x","article-title":"ABO antibody titer and risk of antibody-mediated rejection in ABO-incompatible renal transplantation","volume":"10","author":"Tobian","year":"2010","journal-title":"Am J Transplant"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.2215\/CJN.01060307","article-title":"Parvovirus B19 and the kidney","volume":"2","author":"Waldman","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1086\/596053","article-title":"Investigation of intrarenal viral infections in kidney transplant recipients unveils an association between parvovirus B19 and chronic allograft injury","volume":"199","author":"Barzon","year":"2009","journal-title":"J Infect Dis"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"2198","DOI":"10.1097\/00007890-200005270-00043","article-title":"Parvovirus B19 in kidney transplant patients","volume":"69","author":"Zolnourian","year":"2000","journal-title":"Transplantation"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1038\/ki.2010.423","article-title":"Infection and chronic allograft dysfunction","volume":"78","author":"Dupont","year":"2010","journal-title":"Kidney Int"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1111\/j.1600-6143.2008.02244.x","article-title":"Postrenal transplant hemophagocytic lymphohistiocytosis and thrombotic microangiopathy associated with parvovirus B19 infection","volume":"8","author":"Ardalan","year":"2008","journal-title":"Am J Transplant"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1046\/j.1523-1755.2001.00727.x","article-title":"Association of parvovirus B19 infection with idiopathic collapsing glomerulopathy","volume":"59","author":"Moudgil","year":"2001","journal-title":"Kidney Int"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1681\/ASN.V1161132","article-title":"Thrombotic microangiopathy associated with parvovirus B19 infection after renal transplantation","volume":"11","author":"Murer","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1128\/CMR.00040-16","article-title":"Human parvoviruses","volume":"30","author":"Qiu","year":"2017","journal-title":"Clin Microbiol Rev"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"e14050","DOI":"10.1111\/ctr.14050","article-title":"ABO-incompatible living kidney transplantation","volume":"34","author":"Cen","year":"2020","journal-title":"Clin Transpl"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1111\/ajt.13760","article-title":"Anti-blood group antibodies in intravenous immunoglobulin may complicate interpretation of antibody titers in ABO-incompatible transplantation","volume":"16","author":"Staley","year":"2016","journal-title":"Am J Transplant"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"122","DOI":"10.5500\/wjt.v8.i5.122","article-title":"Thrombotic microangiopathy after renal transplantation: current insights in de novo and recurrent disease","volume":"8","author":"Abbas","year":"2018","journal-title":"World J Transplant"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.trre.2017.10.001","article-title":"De novo thrombotic microangiopathy after kidney transplantation","volume":"32","author":"Garg","year":"2018","journal-title":"Transplant Rev"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1080\/23744235.2021.1893379","article-title":"Parvovirus B19 in kidney transplantation: key points and essential pitfalls to know","volume":"53","author":"Bentata","year":"2021","journal-title":"Infect Dis"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.kint.2023.04.015","article-title":"Application of the banff human organ transplant panel to kidney transplant biopsies with features suspicious for antibody-mediated rejection","volume":"104","author":"Beadle","year":"2023","journal-title":"Kidney Int"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1097\/TP.0000000000002366","article-title":"A 2018 reference guide to the banff classification of renal allograft pathology","volume":"102","author":"Roufosse","year":"2018","journal-title":"Transplantation"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.idc.2010.02.003","article-title":"Viral impact on long-term kidney graft function","volume":"24","author":"Helanter\u00e4","year":"2010","journal-title":"Infect Dis Clin N Am"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"6437392","DOI":"10.1155\/2020\/6437392","article-title":"Parvovirus infection-related anemia after kidney transplantation","volume":"2020","author":"Sharma","year":"2020","journal-title":"Case Rep Transplant"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"241","DOI":"10.4103\/UA.UA_89_19","article-title":"Epidemiology of parvovirus b19 and anemia among kidney transplant recipients: a meta-analysis","volume":"12","author":"Thongprayoon","year":"2020","journal-title":"Urol Ann"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1097\/TP.0b013e3181957308","article-title":"Endothelial progenitor cells possess monocyte-like antigen-presenting and t-cell-co-stimulatory capacity","volume":"87","author":"Raemer","year":"2009","journal-title":"Transplantation"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1745-6150-8-30","article-title":"Designing of interferon-gamma inducing MHC class-ii binders","volume":"8","author":"Dhanda","year":"2013","journal-title":"Biol Direct"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1086\/504812","article-title":"Parvovirus B19 infection after transplantation: a review of 98 cases","volume":"43","author":"Eid","year":"2006","journal-title":"Clin Infect Dis"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"2530","DOI":"10.1016\/j.transproceed.2020.01.091","article-title":"Pure red cell aplasia and antibody-mediated rejection: double trouble in 1 kidney transplant recipient solved by intravenous immunoglobulin infusion: a case report","volume":"52","author":"Knysak","year":"2020","journal-title":"Transpl Proc"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1111\/j.1399-0012.2005.00415.x","article-title":"Incidence and clinical significance of human parvovirus b19 infection in kidney transplant recipients","volume":"19","author":"Ki","year":"2005","journal-title":"Clin Transpl"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1016\/s0140-6736(86)92245-2","article-title":"Parvovirus infection after renal transplant","volume":"328","author":"Neild","year":"1986","journal-title":"Lancet"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3390\/ijms24119147","article-title":"Pre-existing intrarenal parvovirus b19 infection may relate to antibody-mediated rejection in pediatric kidney transplant patients","volume":"24","author":"Bertazza","year":"2023","journal-title":"Int J Mol Sci"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1195419\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T14:30:44Z","timestamp":1700749844000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1195419\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,23]]},"references-count":53,"alternative-id":["10.3389\/fmed.2023.1195419"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2023.1195419","relation":{},"ISSN":["2296-858X"],"issn-type":[{"type":"electronic","value":"2296-858X"}],"subject":[],"published":{"date-parts":[[2023,11,23]]},"article-number":"1195419"}}